This volume presents an up-to-date compendium of major scientific breakthroughs on human diseases, drug screenings, personalized medicine and regenerative approaches by using stem cells to model or treat the disorders
This book covers what would be the desired strategy for the years to come, by methodically dissecting limitations in our current methodology and understanding of stem cells technology
This book also summarizes state-of-the-art technology (genomics and epigenomics, crispr/cas9, epigenetic tools, bioinformatics approaches, etc) that will push further the applicability and validity of the stem cell application in biomedical research
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Raul Delgado-Morales holds a PhD in Neuroscience. He completed his doctoral studies at the Universitat Autònoma de Barcelona working in the field of epigenetics as it relates to depression. After that he received a Marie Curie Postdoctoral Fellowship, to continue his research as a postdoc at the Max Planck Institute of Psychiatry in Munich. There he focused on Alzheimer's disease. After four years in Germany, he moved to Bellvitge Biomedical Research Institute (IDIBELL), in Barcelona, to lead research on neuroepigenomics. Currently he is the Scientific Deputy Director of IDIBELL.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Universitätsbuchhandlung Herta Hold GmbH, Berlin, Allemagne
xi, 426 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch. N° de réf. du vendeur 2189MB
Quantité disponible : 2 disponible(s)
Vendeur : Buchpark, Trebbin, Allemagne
Etat : Hervorragend. Zustand: Hervorragend | Seiten: 440 | Sprache: Englisch | Produktart: Bücher | This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer¿s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment. In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research. N° de réf. du vendeur 29608255/1
Quantité disponible : 1 disponible(s)
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Etat : new. Questo è un articolo print on demand. N° de réf. du vendeur c0e86c81a0a70d0d544c4128bfc9e5b1
Quantité disponible : Plus de 20 disponibles
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9783319906942_new
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book looks at where stem cell technology is presently and how it is instrumentalin advancing the field of disease modeling and cell transplantation. By focusing onmajor human disorders such as Alzheimer's disease, cancer, and heart disorders, thebook summarizes the major findings in the field of human stem cells and dissectthe current limitations on our understanding of stem cells biology. The chaptersfocus on the genetics, genomics, epigenetics and physiology of stem cells models,together with technological advances on molecular biology such as CRISPR/Cas9 orepigenetic editing, that will be instrumental in the future of human disease modelingand treatment.In base of the limitations of current disease models and in front of the unmet necessityof finding therapeutical interventions for human disorders, the availability of stemcell technology has opened new doors for several fields. The unlimited self-renewalcapacity and more extensive differentiation potential of stem cells offers a theoreticallyinexhaustible and replenishable source of any cell subtype. Since Professor ShinyaYamanaka described it, 10 years ago in his seminal paper, that somatic cells could bereprogrammed to inducible stem cells (iPSC) just by expressing four transcriptionfactors, the field of has exploded, especially its applications in biomedical research. 440 pp. Englisch. N° de réf. du vendeur 9783319906942
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Gebunden. Etat : New. N° de réf. du vendeur 220289584
Quantité disponible : Plus de 20 disponibles
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Etat : New. N° de réf. du vendeur V9783319906942
Quantité disponible : 15 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26376276935
Quantité disponible : 4 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer¿s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment.In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 440 pp. Englisch. N° de réf. du vendeur 9783319906942
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book looks at where stem cell technology is presently and how it is instrumentalin advancing the field of disease modeling and cell transplantation. By focusing onmajor human disorders such as Alzheimer's disease, cancer, and heart disorders, thebook summarizes the major findings in the field of human stem cells and dissectthe current limitations on our understanding of stem cells biology. The chaptersfocus on the genetics, genomics, epigenetics and physiology of stem cells models,together with technological advances on molecular biology such as CRISPR/Cas9 orepigenetic editing, that will be instrumental in the future of human disease modelingand treatment.In base of the limitations of current disease models and in front of the unmet necessityof finding therapeutical interventions for human disorders, the availability of stemcell technology has opened new doors for several fields. The unlimited self-renewalcapacity and more extensive differentiation potential of stem cells offers a theoreticallyinexhaustible and replenishable source of any cell subtype. Since Professor ShinyaYamanaka described it, 10 years ago in his seminal paper, that somatic cells could bereprogrammed to inducible stem cells (iPSC) just by expressing four transcriptionfactors, the field of has exploded, especially its applications in biomedical research. N° de réf. du vendeur 9783319906942
Quantité disponible : 1 disponible(s)